![Serene Forte](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Serene Forte worked as an Executive Director-Global Gene Therapy Commercial at Sarepta Therapeutics, Inc., Head-North America Medical Affairs at PTC Therapeutics, Inc., and Vice President-Medical Affairs at Krystal Biotech, Inc. She holds a doctorate degree from the University of Massachusetts Medical School and a graduate degree from Johns Hopkins Bloomberg School of Public Health.
| Companies | Position | End |
|---|---|---|
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| KRYSTAL BIOTECH, INC. | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
UMass Chan Medical School
 UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johns Hopkins Bloomberg School of Public Health
 Johns Hopkins Bloomberg School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Krystal Biotech, Inc.
 Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
